Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 22
Phase 32

Trial Status

Completed3
Other1

Role Distribution

Other Roles4

Activity Timeline

Clinical Trials (4)

NCT06005597Phase 3Completed
Study of Obicetrapib & Ezetimibe Fixed Dose Combination on Top of Maximum Tolerated Lipid-Modifying Therapies
ASCVDDyslipidemiasFamilial Hypercholesterolemia+2 more
StudydirectorStart date: 2024-03-01
NCT05421078Phase 2Completed
A Dose-Finding Study in Japanese Patients to Evaluate the Effect of Obicetrapib as an Adjunct to Stable Statin Therapy.
DyslipidemiaHigh CholesterolHypercholesterolemia
StudydirectorStart date: 2022-06-27
NCT05202509Phase 3Active Not Recruiting
Cardiovascular Outcome Study to Evaluate the Effect of Obicetrapib in Patients With Cardiovascular Disease
Atherosclerotic Cardiovascular Disease
StudydirectorStart date: 2022-02-07
NCT05161715Phase 2Completed
Proof-of-concept, Open-label Study in Patients With Early Alzheimer's Disease
Early Alzheimer's Disease
StudydirectorStart date: 2022-01-12

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (4)

Showing 4 of 4 trials

NCT06005597Phase 3StudyDirector

Study of Obicetrapib & Ezetimibe Fixed Dose Combination on Top of Maximum Tolerated Lipid-Modifying Therapies

ASCVDDyslipidemiasFamilial Hypercholesterolemia+2 more
Completed
NCT05421078Phase 2StudyDirector

A Dose-Finding Study in Japanese Patients to Evaluate the Effect of Obicetrapib as an Adjunct to Stable Statin Therapy.

DyslipidemiaHigh CholesterolHypercholesterolemia
Completed
NCT05202509Phase 3StudyDirector

Cardiovascular Outcome Study to Evaluate the Effect of Obicetrapib in Patients With Cardiovascular Disease

Atherosclerotic Cardiovascular Disease
Active Not Recruiting
NCT05161715Phase 2StudyDirector

Proof-of-concept, Open-label Study in Patients With Early Alzheimer's Disease

Early Alzheimer's Disease
Completed

All 4 trials loaded